Chemoradiotherapy of stage III small-cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence?

Clin Respir J. 2018 Oct;12(10):2534-2535. doi: 10.1111/crj.12951.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Chemoradiotherapy
  • Clinical Trials as Topic
  • Evidence-Based Medicine
  • Humans
  • Lung Neoplasms / therapy*
  • Neoplasm Staging
  • Practice Guidelines as Topic
  • Treatment Outcome